Page last updated: 2024-11-04

sulfamethoxypyridazine and Agranulocytosis

sulfamethoxypyridazine has been researched along with Agranulocytosis in 2 studies

Sulfamethoxypyridazine: A sulfanilamide antibacterial agent.
sulfamethoxypyridazine : A sulfonamide consisting of pyridazine having a methoxy substituent at the 6-position and a 4-aminobenzenesulfonamido group at the 3-position.

Agranulocytosis: A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MINILEYVA, S1
QUINTANILLAULLA, J1
Tuomisto, J1

Other Studies

2 other studies available for sulfamethoxypyridazine and Agranulocytosis

ArticleYear
[RECURRENT AGRANULOCYTOSIS WITH VARIATION OF THE ETIOLOGICAL FACTOR].
    Revista clinica espanola, 1965, Mar-15, Volume: 96

    Topics: Agranulocytosis; Dextropropoxyphene; Drug Hypersensitivity; Sulfamethoxypyridazine; Toxicology

1965
[Side effects of long-acting sulphonamides].
    Duodecim; laaketieteellinen aikakauskirja, 1971, Volume: 87, Issue:5

    Topics: Agranulocytosis; Humans; Protein Binding; Stevens-Johnson Syndrome; Sulfamethoxypyridazine; Sulfonam

1971